PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.86%
Negative net income growth while CRWD stands at 11.98%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.92%
D&A growth well above CRWD's 11.01%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-208.20%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
0.47%
Less SBC growth vs. CRWD's 13.61%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
132.15%
Well above CRWD's 65.57% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
115.46%
AR growth well above CRWD's 70.59%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-170.81%
Negative yoy inventory while CRWD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
121.28%
A yoy AP increase while CRWD is negative at -177.87%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
142.54%
Some yoy usage while CRWD is negative at -10.38%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
134.20%
Well above CRWD's 11.20%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
75.32%
Operating cash flow growth above 1.5x CRWD's 46.63%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
8.95%
Some CapEx rise while CRWD is negative at -4.02%. John Neff would see competitor possibly building capacity while we hold back expansions.
-2102.24%
Negative yoy acquisition while CRWD stands at 1353.69%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-248.22%
Both yoy lines negative, with CRWD at -41.67%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
118.36%
We have some liquidation growth while CRWD is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-1226.97%
Both yoy lines negative, with CRWD at -212.21%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-1292.85%
Both yoy lines negative, with CRWD at -8.65%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
63.92%
We slightly raise equity while CRWD is negative at -90.05%. John Neff sees competitor possibly preserving share count or buying back shares.
-18.69%
We cut yoy buybacks while CRWD is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.